SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-22-012194
Filing Date
2022-02-07
Accepted
2022-02-07 06:12:18
Documents
1
Group Members
HUTCHMED GROUP INVESTMENT LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm224902d1_sc13da.htm SC 13D/A 40560
  Complete submission text file 0001104659-22-012194.txt   42320
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87481 | Film No.: 22595398
SIC: 2834 Pharmaceutical Preparations

Mailing Address 48TH FLOOR, CHEUNG KONG CENTER 2 QUEEN'S ROAD CENTRAL HONG KONG K3 00000
Business Address 48TH FLOOR, CHEUNG KONG CENTER 2 QUEEN'S ROAD CENTRAL HONG KONG K3 00000 852-2121-3888
HUTCHMED (China) Ltd (Filed by) CIK: 0001648257 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations